中文

DHG

₫90,500
+0.00% 2026-09-15 · Close
AI Composite Signal
6.6 / 10
Bullish — 5-signal composite
Mkt Cap
12.1T
₫12.1T
P/E
13.5
P/B
2.7
ROE
20.3%
ROA
17.2%
EPS
6.9K
Price Chart
What matters now

DHG (DHG) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 90,500 VND, little changed on the session, giving a market capitalization of 12.1 trillion VND.

On valuation, DHG trades at a price-to-earnings ratio of 13.5 and a price-to-book of 2.7. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 20.3% points to strong profitability relative to the company's equity base, above the sector average of 11.5%. Trailing earnings per share stand at 6,897 VND.

Aveluro tracks 19 news items mentioning DHG, where recent coverage skews positive (53% of articles). The most recent catalyst was a dividend announcement event — "DGC Leads Vietnam Dividend Week with 80% Cash Payout". Aveluro's composite model rates DHG 6.6/10 (Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Latest catalyst

DGC Leads Vietnam Dividend Week with 80% Cash Payout

Recent Developments

Recent developments around DHG include 5 notable classified events. On Sep 14, 2026, a dividend announcement was reported: Duc Giang Chemicals (DGC) will finalize an 80% cash dividend on 15 September 2026, comprising a 30% 2026 interim and 50% final 2025 payout, equal to VND 8,000 per share. On Aug 31, 2026, a dividend announcement was reported: DHG will pay a 50% cash dividend (VND 5,000/share) on Sept 30, 2025, totaling nearly VND 654 billion, completing a 100% cash dividend for fiscal 2025. On Aug 21, 2026, a dividend announcement was reported: DHG will pay a final 2025 cash dividend of 50% (5,000 VND/share) on September 30, 2026, with a record date of September 15, bringing total 2025 dividends to 100%. On Aug 21, 2026, a dividend announcement was reported: Dược Hậu Giang (DHG) will pay a final cash dividend of 5,000 VND per share (50%) on September 30, completing a 100% cash payout for 2025. On Aug 13, 2026, a market event was reported: SCIC's 2026-2030 restructuring plan targets full divestment from 66 enterprises, potentially adding significant supply to the market, while retaining stakes in 21 firms including Vinamilk (VNM), Sabeco (SAB), and FPT.

The overall tone of recent coverage is positive, with 3 of 5 events carrying bullish sentiment.

AI Signal Breakdown
Bearish Neutral Bullish
6.6 / 10
Bullish
Sentiment
+0.00
Impact
0.40
Momentum
-0.55
Fundamentals
+0.70
Volume
0.54
Sentiment 30% · Impact 20% · Momentum 20% · Fundamentals 15% · Volume 15%
News Sentiment
19
Articles Analyzed
Positive 10
Neutral 6
Negative 3
Recent News
Sep 14, 2026 Full Analysis Neutral dividend announcement
Duc Giang Chemicals (DGC) will finalize an 80% cash dividend on 15 September 2026, comprising a 30% 2026 interim and 50% final 2025 payout, equal to VND 8,000 per share. It is the highest ratio among roughly 39 Vietnamese listed companies closing dividend rights during the 14-18 September 2026 window.
Aug 31, 2026 Full Analysis Positive dividend announcement
DHG will pay a 50% cash dividend (VND 5,000/share) on Sept 30, 2025, totaling nearly VND 654 billion, completing a 100% cash dividend for fiscal 2025. Major shareholders Taisho Pharmaceutical and SCIC will receive the bulk.
Aug 21, 2026 Full Analysis Positive dividend announcement
DHG will pay a final 2025 cash dividend of 50% (5,000 VND/share) on September 30, 2026, with a record date of September 15, bringing total 2025 dividends to 100%. The company also reported H1 2026 net profit up 22% to VND 614 billion, achieving 70% of its full-year pre-tax profit target.
Aug 21, 2026 Full Analysis Positive dividend announcement
Dược Hậu Giang (DHG) will pay a final cash dividend of 5,000 VND per share (50%) on September 30, completing a 100% cash payout for 2025. The company also reported Q2/2026 net profit up 26% year-on-year, with H1 profit reaching 70% of its full-year target.
Aug 13, 2026 Full Analysis Neutral stake change
SCIC's 2026-2030 restructuring plan targets full divestment from 66 enterprises, potentially adding significant supply to the market, while retaining stakes in 21 firms including Vinamilk (VNM), Sabeco (SAB), and FPT. The list is flexible, so actual divestment pace will vary by company and market conditions.
Jul 14, 2026 Full Analysis Positive sector sentiment
DHG, a leading Vietnamese pharmaceutical firm, is at the center of a foreign M&A wave as the market is projected to reach $10 billion by 2026. Taisho Pharmaceutical's acquisition of DHG for an estimated VND 7,000 billion exemplifies the trend, driven by aging demographics and rising healthcare spending.
Jul 14, 2026 Full Analysis Negative regulation change
DHG Pharmaceutical (DHG) faces a VND 10 billion tax penalty and back-tax order for declaration errors, with payment due in 10 days. The fine is small relative to DHG's quarterly net profit of VND 310 billion, but the regulatory action highlights compliance risk.
Jun 25, 2026 Full Analysis Positive dividend announcement
Nam Hoa (NHT) leads Vietnamese listed firms with a 27.3% cash dividend yield for 2025, more than triple the 7.5% bank deposit rate. Other companies like PAP, FPT Online, VEAM, Sabeco, BMP, and DHG also offer yields above 14%.
May 13, 2026 Full Analysis Neutral sector sentiment
Vietnam's top three pharma companies by market cap—DHG, IMP, and DHT—are now under foreign control or significant influence, with Taisho, Livzon, and ASKA as key shareholders. The sector is projected to double from $8-9 billion to $16 billion by 2032, driving M&A interest.
May 11, 2026 Full Analysis Neutral dividend announcement
37 Vietnamese listed companies, including HPG, DHG, and FMC, will close shareholder lists for cash or stock dividends during the week of May 11-15, 2026. DHG leads with a 50% cash dividend (VND 5,000/share), while HPG pays 5% (VND 500/share) and FMC 20% (VND 2,000/share).
May 09, 2026 Full Analysis Positive dividend announcement
LPB (LPBank) announces a record 30% cash dividend for 2025, distributing nearly VND 9,000 billion to shareholders, the highest in its history and among the top in the banking sector. The payout is funded from distributable profits of VND 9,409 billion.
Apr 29, 2026 Full Analysis Positive dividend announcement
DHG Pharma (DHG) will pay a 50% cash dividend (VND 5,000/share) on May 28, 2025, distributing nearly VND 653 billion. Major shareholders Taisho Pharmaceutical (51%) and SCIC (43%) will receive about VND 333 billion and VND 280 billion respectively.
Apr 21, 2026 Full Analysis Negative regulation change
DHG Pharmaceutical (DHG) faces potential delisting as retail shareholder ownership stands at 5.68%, below the 10% minimum required by Vietnamese securities law. The company is in discussions with the State Securities Commission (SSC) and expects a decision within a year, while major shareholders Taisho and SCIC express intent to maintain public status for transparency and brand credibility.
Apr 20, 2026 Full Analysis Positive earnings beat
VNDirect (VND) posted Q1 2026 pre-tax profit of VND 681 billion, a 43% year-on-year increase, as part of a broader earnings release wave. TP Securities (ORS) led with a 1,961% surge to VND 42 billion, while ACBS grew 67% to VND 303 billion, highlighting divergent performance in Vietnam's securities sector amid mixed market conditions.
Related Stocks — Health Care
Stock Analysis

By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-09-15T16:36:25Z.